These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 24389820)

  • 1. Effects of atorvastatin, amlodipine, and their combination on vascular dysfunction in insulin-resistant rats.
    Okamura T; Tawa M; Geddawy A; Shimosato T; Iwasaki H; Shintaku H; Yoshida Y; Masada M; Shinozaki K; Imamura T
    J Pharmacol Sci; 2014; 124(1):76-85. PubMed ID: 24389820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy of amlodipine and atorvastatin has more beneficial vascular effects than monotherapy in salt-sensitive hypertension.
    Zhou MS; Tian R; Jaimes EA; Raij L
    Am J Hypertens; 2014 Jun; 27(6):873-80. PubMed ID: 24413709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling.
    Antoniades C; Bakogiannis C; Leeson P; Guzik TJ; Zhang MH; Tousoulis D; Antonopoulos AS; Demosthenous M; Marinou K; Hale A; Paschalis A; Psarros C; Triantafyllou C; Bendall J; Casadei B; Stefanadis C; Channon KM
    Circulation; 2011 Jul; 124(3):335-45. PubMed ID: 21730307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus.
    Wenzel P; Daiber A; Oelze M; Brandt M; Closs E; Xu J; Thum T; Bauersachs J; Ertl G; Zou MH; Förstermann U; Münzel T
    Atherosclerosis; 2008 May; 198(1):65-76. PubMed ID: 18061195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effect of amlodipine and atorvastatin in reversing LDL-induced endothelial dysfunction.
    Mason RP; Kubant R; Heeba G; Jacob RF; Day CA; Medlin YS; Funovics P; Malinski T
    Pharm Res; 2008 Aug; 25(8):1798-806. PubMed ID: 18087679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal biopterin metabolism is a major cause of impaired endothelium-dependent relaxation through nitric oxide/O2- imbalance in insulin-resistant rat aorta.
    Shinozaki K; Kashiwagi A; Nishio Y; Okamura T; Yoshida Y; Masada M; Toda N; Kikkawa R
    Diabetes; 1999 Dec; 48(12):2437-45. PubMed ID: 10580434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species.
    Wassmann S; Laufs U; Bäumer AT; Müller K; Ahlbory K; Linz W; Itter G; Rösen R; Böhm M; Nickenig G
    Hypertension; 2001 Jun; 37(6):1450-7. PubMed ID: 11408394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation.
    Wagner AH; Köhler T; Rückschloss U; Just I; Hecker M
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):61-9. PubMed ID: 10634801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atorvastatin restores the impaired vascular endothelium-dependent relaxations mediated by nitric oxide and endothelium-derived hyperpolarizing factors but not hypotension in sepsis.
    Subramani J; Kathirvel K; Leo MD; Kuntamallappanavar G; Uttam Singh T; Mishra SK
    J Cardiovasc Pharmacol; 2009 Dec; 54(6):526-34. PubMed ID: 19755915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atorvastatin prevents end-organ injury in salt-sensitive hypertension: role of eNOS and oxidant stress.
    Zhou MS; Jaimes EA; Raij L
    Hypertension; 2004 Aug; 44(2):186-90. PubMed ID: 15238570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atorvastatin prevents angiotensin II-induced vascular remodeling and oxidative stress.
    Briones AM; Rodríguez-Criado N; Hernanz R; García-Redondo AB; Rodrigues-Díez RR; Alonso MJ; Egido J; Ruiz-Ortega M; Salaices M
    Hypertension; 2009 Jul; 54(1):142-9. PubMed ID: 19451411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simvastatin ameliorates angiotensin II-induced endothelial dysfunction through restoration of Rho-BH4-eNOS-NO pathway.
    Zhang Z; Wang M; Xue SJ; Liu DH; Tang YB
    Cardiovasc Drugs Ther; 2012 Feb; 26(1):31-40. PubMed ID: 22083280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term atorvastatin improves age-related endothelial dysfunction by ameliorating oxidative stress and normalizing eNOS/iNOS imbalance in rat aorta.
    Gong X; Ma Y; Ruan Y; Fu G; Wu S
    Exp Gerontol; 2014 Apr; 52():9-17. PubMed ID: 24463049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atorvastatin restores endothelial function in offspring of protein-restricted rats in a cholesterol-independent manner.
    Torrens C; Kelsall CJ; Hopkins LA; Anthony FW; Curzen NP; Hanson MA
    Hypertension; 2009 Apr; 53(4):661-7. PubMed ID: 19221211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does atorvastatin induce aortic smooth muscle cell apoptosis in vivo?
    Doyon M; Hale TM; Huot-Marchand JE; Wu R; de Champlain J; DeBlois D
    Vascul Pharmacol; 2011; 54(1-2):5-12. PubMed ID: 20951229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy with atorvastatin and amlodipine suppresses angiotensin II-induced aortic aneurysm formation.
    Takahashi K; Matsumoto Y; Do e Z; Kanazawa M; Satoh K; Shimizu T; Sato A; Fukumoto Y; Shimokawa H
    PLoS One; 2013; 8(8):e72558. PubMed ID: 23967318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atorvastatin restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoprotein.
    Beckman JA; Liao JK; Hurley S; Garrett LA; Chui D; Mitra D; Creager MA
    Circ Res; 2004 Jul; 95(2):217-23. PubMed ID: 15178637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The protective effect of HMG-CoA reductase inhibitors against monocrotaline-induced pulmonary hypertension in the rat might not be a class effect: comparison of pravastatin and atorvastatin.
    Rakotoniaina Z; Guerard P; Lirussi F; Goirand F; Rochette L; Dumas M; Bardou M
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Dec; 374(3):195-206. PubMed ID: 17102939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibitors on endothelial nitric oxide synthase and the formation of oxidants in the vasculature.
    Parker RA; Huang Q; Tesfamariam B
    Atherosclerosis; 2003 Jul; 169(1):19-29. PubMed ID: 12860247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral administration of tetrahydrobiopterin prevents endothelial dysfunction and vascular oxidative stress in the aortas of insulin-resistant rats.
    Shinozaki K; Nishio Y; Okamura T; Yoshida Y; Maegawa H; Kojima H; Masada M; Toda N; Kikkawa R; Kashiwagi A
    Circ Res; 2000 Sep; 87(7):566-73. PubMed ID: 11009561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.